According to Hefu China's announcement, the cumulative increase deviation value of the company's stock exceeded 20% for three consecutive trading days on December 4, 5 and 8, 2025, which is an abnormal fluctuation. The cumulative increase from October 28 to December 8 was 336.83%, rising and stopping over 16 trading days, hitting abnormal fluctuations 6 times and severe abnormal fluctuations 3 times. As of December 8, the stock price reached a record high of 29.18 yuan/share, with a static price-earnings ratio of 421.35 times, far higher than 28.86 times that of the industry. Net profit for the third quarter of 2025 was -5048 million yuan, a year-on-year decrease of 225.26%. The controlling shareholder has plans to reduce their holdings, but they have not reduced their holdings as of December 8. Investors are reminded to be aware of the risks.

According to Hefu China's announcement, the cumulative increase deviation value of the company's stock exceeded 20% for three consecutive trading days on December 4, 5 and 8, 2025, which is an abnormal fluctuation. The cumulative increase from October 28 to December 8 was 336.83%, rising and stopping over 16 trading days, hitting abnormal fluctuations 6 times and severe abnormal fluctuations 3 times. As of December 8, the stock price reached a record high of 29.18 yuan/share, with a static price-earnings ratio of 421.35 times, far higher than 28.86 times that of the industry. Net profit for the third quarter of 2025 was -5048 million yuan, a year-on-year decrease of 225.26%. The controlling shareholder has plans to reduce their holdings, but they have not reduced their holdings as of December 8. Investors are reminded to be aware of the risks.